Recombinant Human CCR5 Protein，His

CCR5 (C-C chemokine receptor type 5) is a crucial protein functioning as a co-receptor for HIV-1 entry into host cells, facilitating viral fusion and infection. Its role in the immune system, particularly in the inflammatory response, has made it a significant target for therapeutic interventions in HIV treatment and potential vaccines. Researchers have been investigating CCR5 for its involvement in various other diseases, including cancer and autoimmune disorders, due to its impact on cell signaling and migration. The development of CCR5 antagonists, such as maraviroc, heralded a new class of antiviral drugs, enhancing the understanding of how blocking this receptor could lead to better management of HIV. Moreover, genetic studies have identified mutations like CCR5-Δ32 that confer resistance to HIV infection, sparking interest in gene therapy approaches. In recent years, recombinant protein technologies have enabled the production of CCR5 protein for structural and functional studies, paving the way for innovative research in drug design and therapeutic applications. Understanding the precise mechanisms of CCR5 interactions at a molecular level continues to be of great importance, aiming to exploit its pathways not only for combating HIV but also for broader applications in treating related conditions, thereby advancing both virology and immunology fields.